The 20 Best Myasthenia Gravis Doctors Near Me in Ann Arbor, MI

Wayne Cornblath is a Neurologist and an Ophthalmologist in Ann Arbor, Michigan. Dr. Cornblath is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis.

Ann Little is a Neurologist and a Neuroradiologist in Ann Arbor, Michigan. Dr. Little is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy.

Gary Gallagher, MD completed his undergraduate bachelor of science degree in Industrial and Operations Engineering at the University of Michigan. An interest in health sciences, lead him to attend medical school at Wayne State University of Medicine in Detroit, MI where he received his doctorate of medicine in 2008. He completed residency in neurology and fellowship in neuromuscular medicine at the University of Michigan. During final year of residency, he served as chief resident. Following completion of fellowship, Dr. Gallagher joined the neurology faculty at the University of Michigan.Dr. Gallagher is interested in the clinical care of neuromuscular disease, tele-medicine, electrodiagnostic procedures (EMG and intraoperative monitoring). His clinical time is spent in the outpatient neuromuscular clinic providing longitudinal care for patients and on the inpatient service caring for acute neurologic problems including stroke management, epilepsy, neuromuscular crisis and auto-immune neurologic disease. In addition, he has strong interest in medical trainee education and he serves as the neuromuscular fellowship director at the University of Michigan. Finally, Dr. Gallagher has strong interest in patient safety and quality improvement and oversees departmental efforts to improve. Dr. Gallagher is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Multifocal Motor Neuropathy, Inclusion Body Myositis, and Peripheral Neuropathy.

Sindhu Ramchandren is a Neurologist in Ann Arbor, Michigan. Dr. Ramchandren is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Charcot-Marie-Tooth Disease, Myasthenia Gravis, Limb-Girdle Muscular Dystrophy Type 1A, and Limb-Girdle Muscular Dystrophy Type 2B.

From 2013 to 2015 Dr. De Lott studied for and obtained an MS, Health and Healthcare Research at the University of Michigan, Rackham Graduate School in Ann Arbor, Michigan. Dr. Delott is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Optic Neuritis, Papilledema, Pseudotumor Cerebri Syndrome, and Increased Intracranial Pressure.

Dr. Elafros graduated Phi Beta Kappa and with honors from Michigan State University in Human Biology and Spanish before completing a Masters of Arts in Bioethics. She then received her MD degree and PhD in Epidemiology from Michigan State University during which time she lived in Zambia for two years to complete her doctoral dissertation which examined the medical and psychosocial burden of HIV and epilepsy among adults in the capital city Lusaka. Dr. Elafros then completed a neurology residency at Johns Hopkins Hospitals, during which time she received an R25 from the National Institutes of Health which allowed her to return to Zambia to examine barriers to care for patients with meningitis. She then joined the University of Michigan for neuromuscular fellowship in 2020.Dr. Elafros provides longitudinal patient care through the outpatient neuromuscular clinic at the University of Michigan. Dr. Elafros is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Peripheral Neuropathy, Myasthenia Gravis, Diabetic Neuropathy, and Seizures.

Dr. Callaghan completed his medical degree and neurology residency at the University of Pennsylvania. He completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master's degree program in clinical research at the University of Michigan School of Public health. Dr. Callaghan is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Thrombectomy, and Thymectomy.

Garrett Conyers graduated Phi Beta Kappa and with honors from Morehouse College. He received his MD from Harvard Medical School during which time he also completed a Masters in Public Policy from the Harvard Kennedy School of Government. He took two years off in medical school to lead a community participatory research project looking into health inequities in underserved communities in Boston. Dr. Conyers then completed a neurology residency at the Johns Hopkins Hospital followed by a fellowship in vascular neurology at the University of Michigan. Clinically, he has a special interest in moyamoya disease and shared decision making. He is involved in several diversity, equity and inclusion committees nationally. He is passionate about healthcare equity and optimizing systems of care for vulnerable populations, such as imprisoned and socioeconomically disadvantages patients. Dr. Conyers is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Stroke, Moyamoya Disease, Dysarthria, Thrombectomy, and Transmyocardial Revascularization.

Mollie McDermott, MD, MS, is an assistant professor in the Department of Neurology. She completed subspecialty training in Vascular Neurology. She received her bachelor’s degree from Mount Holyoke College and her medical degree from Dartmouth Medical School. Dr. McDermott completed her residency training in Neurology at the University of Michigan, where she served as chief resident from 2014 to 2015. In 2017 she received her master of science degree in clinical research design and statistical analysis from the University of Michigan.Dr. McDermott is interested in acute stroke management, secondary stroke prevention, cardioembolic stroke, and atypical causes of stroke. She is the director of the Telestroke Program and the medical director of the Comprehensive Stroke Center. Dr. Mcdermott is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Stroke, Dysarthria, Cardiac Amyloidosis, Stent Placement, and Transmyocardial Revascularization.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist in Ann Arbor, Michigan. Dr. Knierbein is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy.

Alan D. Salgado, M.D. is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Salgado grew up in Gainesville, Florida. He graduated Summa Cum Laude from the University of Florida in 2011. Prior to attending medical school, he completed a postbaccalaureate research training fellowship at the National Institutes of Health. In 2016 he graduated from the University of Florida College of Medicine. He completed a preliminary medicine internship at MedStar Georgetown University Hospital, followed by neurology residency at Vanderbilt University Medical Center. He further completed a fellowship in neuromuscular medicine and EMG at Duke University Medical Center.Dr. Salgado joined the neurology faculty at the University of Michigan in 2022. Dr. Salgado is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Thrombectomy.

Stephen Goutman, MD, MS is an Associate Professor in the Department of Neurology and Director of the Amyotrophic Lateral Sclerosis Clinic and ALS Center of Excellence at Michigan Medicine. After obtaining a degree in neuroscience at the Johns Hopkins University (Baltimore, MD), Dr. Goutman completed his medical degree at the University of Chicago Pritzker School of Medicine (Chicago, IL) and his neurology residency and neuromuscular fellowship at Cleveland Clinic (Cleveland, OH). He received a Master’s in Clinical Research Design and Statistical Analysis at the University of Michigan (Ann Arbor, MI).Dr. Goutman evaluates and treats patients with neuromuscular diseases and is interested in diseases such as myasthenia gravis and muscle diseases. His area of expertise is amyotrophic lateral sclerosis (ALS)/Lou Gehrig’s Disease where his focus is delivering comprehensive and compassionate care. He is Director of the ALS Clinic, an ALS Association Certified Center of Excellence (http://www.umich-als.org/), where he leads a team of providers that care for persons with ALS and their families. Dr. Goutman is inspired by his patients and thus aims to provide the highest level of care.Dr. Goutman’s research is focused on identifying causes of and treatments for ALS. He leads research efforts that received funding by the National Institutes of Health and the Centers for Disease Control aimed at identifying environmental risk factors and causes of ALS (https://umhealthresearch.org/#studies/HUM00028826) and showed, in an article that received widespread attention, a connection between ALS and organochlorine pesticides (https://jamanetwork.com/journals/jamaneurology/fullarticle/2519875). Dr. Goutman also helps direct the University of Michigan ALS Biorepository which provides essential resources to ALS researchers within and external to the University of Michigan enabling studies into areas of ALS genetics, epigenetics, and immunology.Dr. Goutman is a site principal investigator of several multisite clinical trials focused on identifying new ALS treatments and causes and is an active participant with the Northeast ALS Consortium (NEALS) to improve care for ALS. He received a 2016 Young Investigator Award by the World Federation of Neurology Research Group on Motor Neuron Diseases. Dr. Goutman is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy.

Savannah Quigley is a Neurologist and a Neuromusculoskeletal Medicine provider in Ann Arbor, Michigan. Dr. Quigley is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Dr. Sieloff received his bachelor's degree in Biomedical Engineering at the University of Michigan. He then completed both medical school, 2013, and residency, 2017, at University of Michigan, serving as chief neurology resident during his final year of residency. As faculty, he works as a neuro-hospitalist and tele-neurologist, in addition to caring for patients in both the general and multiple sclerosis neurology clinics. Dr. Sieloff is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Conversion Disorder, Guillain-Barre Syndrome, and Gastrostomy.

Douglas J. Gelb, M.D., Ph.D., is a professor in the Department of Neurology in the University of Michigan Medical School. He is considered a national leader in neurologic education, and is part of a small group of investigators who have conducted research in the field. After earning a Bachelor of Arts in physics from Harvard College in 1977, Dr. Gelb completed his doctorate (1982) and medical degree (1984) at the Pritzker School of Medicine at the University of Chicago. He joined the U-M faculty after completing his neurology residency at the University of California, San Francisco in 1988. In 1992, Dr. Gelb became director of the third-year medical student neurology clerkship, and developed a syllabus that eventually evolved into a textbook. It is required or recommended by many neurology clerkships across the country, and it has been translated into two languages. In 2004, Dr. Gelb became director of a new second-year medical school course on diseases of the nervous system. In addition to his textbook, Dr. Gelb has developed a variety of educational materials, including a computer tutorial to teach the principles of neurologic localization. He has written examination questions and served on test-writing committees for the National Board of Medical Examiners Step 2 Examination and the NBME subject examination in neurology, the American Academy of Neurology (AAN) Resident Inservice Training Examination, and Continuum, a widely-used resource for continuing medical education produced by the AAN. He also has served as an examiner for the Oral Examination of the American Board of Psychiatry and Neurology (ABPN) on numerous occasions. Dr. Gelb is frequently honored by neurology residents, who have awarded him the Status Pedagogicus Award on four separate occasions. He has received numerous other awards for his teaching, including the Kaiser Permanente Award for Excellence in Teaching from the U-M, and the Distinguished Neurology Teacher Award from the American Neurological Association. He is a former chair of the national Consortium of Neurology Clerkship Directors, and of the American Academy of Neurology's A.B. Baker Section on Neurological Education. Dr. Gelb is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Trigeminal Neuralgia, Migraine, Migraine with Brainstem Aura, and Seizures.

After graduating from Tehran University of Medical Sciences in 1990, Dr. Sohrab spent time in Spinal Cord Injury Centers of Iran, in multiple capacities, organizing care and educating different levels of practitioners in providing care for veterans of war. He then spent a few years of general practice, in different parts of Iran, dedicated to providing medical care and organizing Public Health Services, in rural areas. Dr. Sohrab has been practicing, and teaching, general Neurology at the University of Michigan, since 2012. Dr. Sohrab is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Migraine, Vertigo, Migraine with Brainstem Aura, and Trigeminal Neuralgia.

Dr. Selwa was born and raised in Michigan, received her undergraduate degree at Harvard University and returned to Michigan for medical school, neurology residency and an epilepsy fellowship. She serves the department of neurology both as Associate Chair for Clinical Services, as co-director of the epilepsy program, and as director of the Clinical Neurophysiology Fellowship Program. Dr. Selwa sees patients with epilepsy, as well as many other patients with a wide spectrum of neurologic disorders.Her scholarly work has focused on cognitive function in epilepsy, sleep in epilepsy, and quality of life outcomes in patients with epilepsy. She also works to improve education for neurologists, as well as the education of other medical specialists and the general public about neurologic illnesses including epilepsy, sleep disorders and coma. Dr. Selwa is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Seizures, Partial Familial Epilepsy, Memory Loss, and Partial Seizure.

Dr. Schuetz completed her medical degree and a master’s degree in psychology at Eberhard-Karls-Universität in Tübingen, Germany. She completed a residency in neurology and a fellowship in clinical neurophysiology/EMG at Mount Sinai School of Medicine in New York City, as well as a sleep medicine fellowship at New York University. Dr. Schuetz is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Restless Legs Syndrome, and CAPOS Syndrome.